This inventor holds 67 USPTO granted patents and 9 published patent applications, plus 7 CIPO patents and 33 EPO patents, primarily in Peptidomimetics Research (CPC class C07K). Top assignees: Polyphor Ag, Polyphor Ltd., Unversität Zürich. Active years: 2005-2023.
Inventors with similar research interests:
Location History:
- Basel, CH (2005 - 2007)
- Blättwil, CH (2011 - 2014)
- Blättwil, CN (2014)
- Battwil, CH (2009 - 2020)
- Baettwil, CH (2013 - 2022)
- Bättwil, CH (2008 - 2023)
Company Filing History:
32 out of 35 
28 out of 28 
19 out of 276 
Years Active: 2005-2023
Areas of Expertise:
Introduction
Daniel Obrecht, located in Bättwil, Switzerland, is a prolific inventor with an impressive portfolio of 67 patents to his name. His contributions to the field of antimicrobial compounds highlight his innovative spirit and commitment to advancing healthcare solutions.
Latest Patents
Among his latest patents are two significant contributions related to Beta-hairpin peptidomimetics. The first patent involves Beta-hairpin peptidomimetics of the general formula (I), specifically cyclo[P-P-P-P-P-P-P-P-P-P-P-P-T-T]. These compounds and their pharmaceutically acceptable salts demonstrate Gram-negative antimicrobial activity and can effectively inhibit the growth or kill various microorganisms. They serve as potential medicaments for treating or preventing infections, as well as disinfectants for foodstuffs, cosmetics, and nutrient-containing materials. These peptidomimetics are manufactured through a mixed solid- and solution-phase synthetic strategy.
The second patent also focuses on Beta-hairpin peptidomimetics of the general formula (I), encompassing components such as P, X, Q, and optionally L, as defined in the associated description and claims. Similar to the first, these compounds show significant Gram-negative antimicrobial activity and potential applications in medical and disinfectant products.
Career Highlights
Daniel Obrecht has made substantial contributions during his tenure in the pharma industry. Notably, he has worked with Polyphor AG and Polyphor Ltd., where his expertise in peptide chemistry has led to innovative developments in the field of antimicrobial agents.
Collaborations
Throughout his career, Daniel has collaborated with esteemed professionals such as Frank Gombert and Christian Ludin. These partnerships have undoubtedly fostered an environment of creativity and innovation, which is essential for advancing scientific research and product development in healthcare.
Conclusion
Daniel Obrecht's extensive patent portfolio and collaborations underscore his significant impact on the scientific community. His work on Beta-hairpin peptidomimetics, in particular, showcases his commitment to addressing critical healthcare challenges through innovative solutions. As he continues to make strides in his field, the influence of his inventions on medicine and public health is sure to be profound.